Erlotinib Recruiting Phase 1 Trials for Malignancies / Malignant Neoplasm of Pancreas Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03403049Carbon Ion Radiation Therapy for Locally Advanced Pancreatic Cancer
NCT02154737Gemcitabine and Pulse Dose Erlotinib in Second Line Treatment of Advanced Pancreatic Cancer